Table 1.

Th17 proportion in peripheral blood from pancreatic cancer patients and healthy control

Group	N	Th17%	IL-17
Healthy control	20	8.72±1.04	67.86±11.08
Early stage	5	6.12±2.14**	51.20±12.14**
Progression stage	15	5.50±1.35**	45.32±10.25**
Advanced stage	20	1.99±0.46**,##	17.87±1.29**

^** P<0.01 compared with healthy control;

^## P<0.01 compared with progression stage group.